SCHEMBL2855210

SCHEMBL2855210

CC1(C)OC(=O)c2ccccc2O1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
TSHR P16473 2/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
CFTR P13569 1/20 0.38
GOPC Q9HD26 1/20 0.38
PKM P14618 1/20 0.38
ATM Q13315 1/20 0.37
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
ALOX15 P16050 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PLA2G1B P04054 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38663321 0.84 TSHR (0.60) ALDH1A1TSHRHTTHPGDSMN1; SMN2
SCHEMBL27182351 0.81 ALDH1A1 (0.45) ALDH1A1TSHRMAPTHPGDCFTR
SCHEMBL13500037 0.78 TSHR (0.42) ALDH1A1TSHRHTTMAPTHPGD
SCHEMBL29442756 0.78 TSHR (0.58) ALDH1A1TSHRHTTMAPTHPGD
SCHEMBL370061 0.78 TSHR (0.58) ALDH1A1TSHRHTTMAPTHPGD
SCHEMBL1165494 0.76 ALDH1A1 (0.45) ALDH1A1TSHRMAPT
SCHEMBL734522 0.76 KDM4E (0.47) ALDH1A1TSHRHTTMAPTSMN1; SMN2
SCHEMBL31217600 0.76 HTR2A (0.43) ALDH1A1TSHRHTTSMN1; SMN2MAPK1
SCHEMBL31217568 0.76 SIRT1 (0.46) ALDH1A1HTTMAPTHPGDSMN1; SMN2
SCHEMBL8137812 0.76 MAPT (0.40) ALDH1A1TSHRHTTMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230244149-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-03 US disclosed
CN-110234638-B Heteroaryl phenoxy benzamide KAPPA opioid ligands 辉瑞大药厂 2022-10-21 CN disclosed
CN-113316568-A 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin 全球血液疗法股份有限公司 2021-08-27 CN disclosed
US-10414743-B2 Polymerizable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2019-09-17 US disclosed
US-20160159763-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-06-09 US disclosed
US-20160159763-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-06-09 US disclosed
US-9279082-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2016-03-08 US disclosed
US-9279082-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2016-03-08 US disclosed
US-9248199-B2 1:1 adducts of sickle hemoglobin GLOBAL BLOOD THERAPEUTICS, INC. (US) 2016-02-02 US disclosed
US-9248199-B2 1:1 adducts of sickle hemoglobin GLOBAL BLOOD THERAPEUTICS, INC. (US) 2016-02-02 US disclosed
US-7265152-B2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases VIROPHARMA INCORPORATED (US) 2007-09-04 US disclosed
US-20070191554-A1 CURABLE FLUOROPOLYETHER COMPOSITIONS AND INTEGRAL MOLDED RESIN/RUBBER ARTICLES SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-08-16 US disclosed
US-20070191554-A1 CURABLE FLUOROPOLYETHER COMPOSITIONS AND INTEGRAL MOLDED RESIN/RUBBER ARTICLES SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-08-16 US disclosed
EP-1818367-A1 Curable fluoropolyether compositions and integral molded resin/rubber articles Shin-Etsu Chemical Co., Ltd. (JP) 2007-08-15 EP disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
WO-2007010514-A2 COMPOUNDS AND THEIR SALTS SPECIFIC TO THE PPAR RECEPTORS AND THE EGF RECEPTORS AND THEIR USE IN THE MEDICAL FIELD GIULIANI INTERNATIONAL LIMITED (IE) 2007-01-25 WO disclosed
EP-1654247-A1 ALKYNYL ARYL CARBOXAMIDES Applied Research Systems ARS Holding N.V. (AN) 2006-05-10 EP disclosed
WO-2005012280-A1 ALKYNYL ARYL CARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-02-10 WO disclosed
EP-0873318-A1 HETEROCYCLICALLY SUBSTITUTED SALICYLIC ACID DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1998-10-28 EP disclosed
WO-1997012879-A1 HETEROCYCLICALLY SUBSTITUTED SALICYLIC ACID DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1997-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10414743-B2 Polymerizable compounds and the use thereof in liquid-crystal displays VCL, LPXN, ACP3 ALDH1A1 3312/4885TSHR 4880/4885HTT 939/4885
US-20160159763-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, LPXN, LCP1 ALDH1A1 3579/4885TSHR 4877/4885HTT 1033/4885
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS ALDH1A1 1454/4885TSHR 1436/4885HTT 1134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.